Lidocaine Ointment USP recall (Direct Rx)
DrugClass IIOngoing
Summary: Direct Rx is recalling Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50. Reason: Subpotent Drug.
What is being recalled
Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
Why
Subpotent Drug
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
Nationwide within the United States
How to tell if yours is affected
LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0107-2027 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | September 29, 2026 |
| Reported | November 4, 2026 |
| Company | Direct Rx |
| Company location | Dawsonville, GA, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 493 jars |
More recalls from Direct Rx · all drug recalls · recalls from September 2026